About
Hy2Care® BV is a Dutch medical technology company established in 2014 as a spin-off from the Tech Med Centre of the University of Twente. Co-founded by Dr. Sanne Both and Prof. Marcel Karperien, the company focuses on developing innovative solutions for cartilage repair to enable natural healing and restore painless mobility. The flagship product, CartRevive®, is a hydrogel implant designed for the functional recovery of cartilage defects, particularly in the knee. This hydrogel mimics joint tissue and forms a bio-adhesive, resorbable scaffold when injected into cartilage defects. It attaches to healthy cartilage, protects the injured area, and promotes true cartilage regeneration, aiming to provide lasting repairs that reduce pain and prevent post-traumatic osteoarthritis. Hy2Care is committed to safety and quality, operating under an ISO 13485:2016 certified Quality Management System. The company is actively involved in clinical investigations and is exploring additional orthopedic applications for its hydrogel technology. Their mission is to enhance patients' quality of life through effective, biologically based cartilage repair solutions.
Technologies
Keywords
Company Information
-
Employees 16
-
Founded 2014
-
Total Funding $9187548
Location
511 Hengelosestraat, Enschede, Overijssel, Netherlands, 7521 AG